* How are Covered Entities handling Trading Partner Agreements in this interim period, prior to the mandated compliance date, to address initial or phased implementations of transactions that are not fully compliant? (Code Sets and data usage may not be fully compliant...) * What type of language is being used in Trading Partner Agreements to differentiate the interim non-compliant transaction from a standard HIPAA transaction? How are these interim timeframes being outlined? * Are Covered Entities planning to use supplemental/companion documents to address interim non-compliance, separate from a Trading Partner Agreement? * I am interested to learn if Covered Entities are following the recommendation in the WEDI/SNIP Trading Partner Agreements White Paper to use a special value in the Identifier Code GS08, such as a "P", to keep the GS08 within data definitions, but showing it is not a compliant transaction.
Any information would be appreciated. Laura A. Mosesso Coventry Health Care Manager, HIPAA/EDI Compliance Information Systems Email: [EMAIL PROTECTED] ********************************************************************** To be removed from this list, send a message to: [EMAIL PROTECTED] Please note that it may take up to 72 hours to process your request.
